@article{e40bbbcb17074af48a223e938122ae07,
title = "Prescriber Behavior in Clostridioides difficile Testing: A 3-Hospital Diagnostic Stewardship Intervention",
abstract = "Computerized clinical decision support (CCDS) significantly reduced Clostridioides difficile testing at 3 hospitals; from 12.6 to 9.5, from 10.1 to 6.4, and from 14.0 to 9.6 average weekly tests per 1000 inpatient days. There were no related adverse events. Senior providers were more likely than interns or residents to follow CCDS.",
keywords = "C. difficile, computerized clinical decision support, diagnostic stewardship intervention, provider behavior",
author = "Masako Mizusawa and Small, {Bryce A.} and Hsu, {Yea Jen} and Sharara, {Sima L.} and Edina Advic and Christopher Kauffman and Milstone, {Aaron M.} and Leonard Feldman and Pahwa, {Amit K.} and Trivedi, {Julie B.} and Landrum, {Mark B.} and Maragakis, {Lisa L.} and Carroll, {Karen C.} and Cosgrove, {Sara E.} and Clare Rock",
note = "Funding Information: The authors thank the microbiology laboratory technologists, the Johns Hopkins Hospital Epic team members, the Johns Hopkins High Value Practice Alliance, the Department of Hospital Epidemiology and Infection Prevention, and the Department of Antimicrobial Stewardship for their ongoing cooperation and assistance with this initiative. We received funding from the CDC for the Clostridium difficile Over Testing (C-DOT) Improvement initiative; a Multi-Prevention Epicenter Collaborative Project (Grant #1 U01 CK000554-01). Funding Information: Financial support. We received funding from the CDC for the Clostridium difficile Over Testing (C-DOT) Improvement initiative; a Multi-Prevention Epicenter Collaborative Project (Grant #1 U01 CK000554-01). Funding Information: Potential conflicts of interest. K. C. C. has received grants from GenPOC, Inc and Singulex, Inc. S. E. C. has received personal fees from Novartis and Theravance. L. L. M. has received grants from the Centers for Disease Control and Prevention (CDC) and Clorox, Inc. C. R. has received a grant from the Clorox Company and the CDC. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Publisher Copyright: {\textcopyright} 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.",
year = "2019",
month = nov,
day = "13",
doi = "10.1093/cid/ciz295",
language = "English (US)",
volume = "69",
pages = "2019--2021",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "11",
}